Page last updated: 2024-10-25

cimetidine and Interstitial Cell Tumor

cimetidine has been researched along with Interstitial Cell Tumor in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leslie, GB1
Noakes, DN1
Pollitt, FD1
Roe, FJ1
Walker, TF1

Other Studies

1 other study available for cimetidine and Interstitial Cell Tumor

ArticleYear
A two-year study with cimetidine in the rat: assessment for chronic toxicity and carcinogenicity.
    Toxicology and applied pharmacology, 1981, Volume: 61, Issue:1

    Topics: Animals; Carcinogens; Cimetidine; Female; Guanidines; Leydig Cell Tumor; Liver; Male; Neoplasms, Exp

1981